SMTL ID : 6lxy.4 (3 other biounits)

IRAK4 in complex with inhibitor

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.19 Å

Oligo State

monomer

Ligands

1 x SO4: SULFATE ION(Non-functional Binders)

SO4.1: 2 residues within 4Å: Chain A: D.267, S.268 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:S.268, A:S.268

1 x EXF: N-[(2R)-2-fluoranyl-3-methyl-3-oxidanyl-butyl]-6-[(6-fluoranylpyrazolo[1,5-a]pyrimidin-5-yl)amino]-4-(propan-2-ylamino)pyridine-3-carboxamide(Non-covalent)

EXF.2: 19 residues within 4Å: Chain A: I.30, M.37, V.45, A.56, K.58, V.91, Y.107, V.108, Y.109, M.110, P.111, N.112, G.113, S.114, D.117, R.118, T.125, L.163, S.173 14 PLIP interactions: 14 interactions with chain A Hydrophobic interactions: A:V.45, A:V.45, A:T.125, A:L.163 Hydrogen bonds: A:V.108, A:M.110, A:M.110, A:G.113 Water bridges: A:S.114, A:D.117, A:R.118, A:D.174 pi-Stacking: A:Y.107, A:Y.107

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Nair, S. et al., Optimization of Nicotinamides as Potent and Selective IRAK4 Inhibitors with Efficacy in a Murine Model of Psoriasis. Acs Med.Chem.Lett. (2020)

Release Date

2020-11-25

Peptides

Interleukin-1 receptor-associated kinase 4: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
E

Interleukin-1 receptor-associated kinase 4

Related Entries With Identical Sequence